These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31220100)

  • 1. Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy.
    Chimura M; Yamada S; Taniguchi Y; Yasaka Y; Kawai H
    PLoS One; 2019; 14(6):e0217865. PubMed ID: 31220100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
    Tateishi E; Noguchi T; Goto Y; Morita Y; Ishibashi-Ueda H; Yamada N; Kanzaki H; Nishimura K; Miyamoto Y; Anzai T; Ogawa H; Yasuda S
    Heart; 2015 May; 101(10):774-80. PubMed ID: 25761994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis.
    Becker MAJ; Cornel JH; van de Ven PM; van Rossum AC; Allaart CP; Germans T
    JACC Cardiovasc Imaging; 2018 Sep; 11(9):1274-1284. PubMed ID: 29680351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events.
    Kasama S; Toyama T; Kaneko Y; Iwasaki T; Sumino H; Kumakura H; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1056-64. PubMed ID: 22415599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
    Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
    Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic stratification by a combination of (123)I-metaiodobenzylguanidine scintigraphy and ejection fraction in dilated cardiomyopathy.
    Momose M; Okayama D; Nagamatsu H; Kondo C; Hagiwara N; Sakai S
    Ann Nucl Med; 2011 Jul; 25(6):419-24. PubMed ID: 21461599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cardiac magnetic resonance-based personalized risk stratification model in dilated cardiomyopathy: a prospective study.
    Zhou D; Zhu L; Wu W; Zhuang B; He J; Xu J; Yang W; Wang Y; Li S; Sun X; Sharma P; Liu G; Sirajuddin A; Arai A; Zhao S; Lu M
    Eur Radiol; 2024 Jun; 34(6):4053-4064. PubMed ID: 37950081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of adverse cardiac events in dilated cardiomyopathy using cardiac T2* MRI and MIBG scintigraphy.
    Nagao M; Baba S; Yonezawa M; Yamasaki Y; Kamitani T; Isoda T; Kawanami S; Maruoka Y; Kitamura Y; Abe K; Higo T; Sunagawa K; Honda H
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):399-407. PubMed ID: 25348658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Chimura M; Onishi T; Tsukishiro Y; Sawada T; Kiuchi K; Shimane A; Okajima K; Yamada S; Taniguchi Y; Yasaka Y; Kawai H
    Heart; 2017 May; 103(9):679-686. PubMed ID: 27799316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy.
    Kamiyoshi Y; Yazaki Y; Urushibata K; Koizumu T; Kasai H; Izawa A; Kinoshita O; Hongo M; Ikeda U
    Am J Cardiol; 2008 May; 101(10):1482-6. PubMed ID: 18471462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy.
    Barison A; Aimo A; Ortalda A; Todiere G; Grigoratos C; Passino C; Camici PG; Aquaro GD; Emdin M
    Int J Cardiol; 2018 Jan; 250():195-200. PubMed ID: 29107357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of beta-blockers in patients with dilated cardiomyopathy from the standpoint of long-term prognosis.
    Fujimoto S; Inoue A; Hisatake S; Yamashina S; Yamashina H; Nakano H; Yamazaki J
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1356-61. PubMed ID: 15221293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
    Narita M; Kurihara T
    J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.
    Romano S; Judd RM; Kim RJ; Kim HW; Klem I; Heitner JF; Shah DJ; Jue J; White BE; Indorkar R; Shenoy C; Farzaneh-Far A
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1419-1429. PubMed ID: 29361479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Quantitative T2 Mapping on Cardiovascular Magnetic Resonance Imaging with Metaiodobenzylguanidine Scintigraphy and Left Ventricular Functional Recovery in Dilated Cardiomyopathy: A Retrospective Pilot Study.
    Ito T; K Kono A; Takamine S; Shigeru M; Mori S; Takaya T; Fujiwara S; Nishii T; Shiotani H; Sugimura K; Hirata K
    Intern Med; 2015; 54(17):2121-8. PubMed ID: 26328635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement.
    Halliday BP; Baksi AJ; Gulati A; Ali A; Newsome S; Izgi C; Arzanauskaite M; Lota A; Tayal U; Vassiliou VS; Gregson J; Alpendurada F; Frenneaux MP; Cook SA; Cleland JGF; Pennell DJ; Prasad SK
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1645-1655. PubMed ID: 30219397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of dilated cardiomyopathy: prognostic benefit of identifying late gadolinium enhancement in Asian patients.
    Infante AN; Koo CCY; Yip A; Lim YH; Yeo WT; Quek ST; Lim TW; Seow SC; Chai P; Ong CC; Teo L; Singh D; Kojodjojo P
    Singapore Med J; 2021 Jul; 62(7):347-352. PubMed ID: 31820004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Feature-Tracking Circumferential Strain in Dilated Cardiomyopathy Patients with Severely Reduced Ejection Fraction Incremental to Late Gadolinium Enhancement.
    Shu SL; Wang J; Wang C; Zhu F; Jia YX; Zhang L; Zhou XY; Zhang TJ; Zheng CS
    Curr Med Sci; 2021 Feb; 41(1):158-166. PubMed ID: 33582921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognostic value of combined free triiodothyronine and late gadolinium enhancement in nonischemic dilated cardiomyopathy.
    Zhang K; Wang W; Zhao S; Katz SD; Iervasi G; Gerdes AM; Tang YD
    Clin Cardiol; 2018 Jan; 41(1):96-103. PubMed ID: 29360143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term prognostic importance of late gadolinium enhancement in first-presentation non-ischaemic dilated cardiomyopathy.
    Sree Raman K; Nucifora G; Leong DP; Marx C; Shah R; Woodman RJ; Molaee P; Shirazi MG; McGavigan AD; De Pasquale CG; Selvanayagam JB
    Int J Cardiol; 2019 Apr; 280():124-129. PubMed ID: 30679073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.